Patent · US Active

Method of reducing chemotherapy-induced neutropenia

US11400086B2 · kind B2 · utility

1Cited by
47References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 1, 2018
Grant dateAug 2, 2022
Priority date—
Expiry dateFeb 1, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are plinabulin and the use for reducing neutropenia. Some embodiments relate to reducing the docetaxel induced neutropenia using plinabulin.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.